Literature DB >> 2290855

Biochemistry and genetics of monoamine oxidase.

W Weyler1, Y P Hsu, X O Breakefield.   

Abstract

This chapter reviews the two mitochondrial flavin containing isozymes of monoamine oxidase. Section 1, "Biochemistry" discusses assays, substrates and inhibitors, phylogenic and tissue distribution, interactions with lipids, nutritional studies, protein structure, kinetic and chemical mechanistic proposals, and biosynthesis. Section 2, "Inheritance" discusses possible genes involved in expression, genetic studies of platelet MAO-B and fibroblast MAO-A, and chromosomal location. Section 3, "Molecular Genetics" reviews the cloning of their cDNAs, their intra- and interspecies homology and structural inferences made from deduced amino acid sequences. Section 4, "Regulation" gives an overview of levels in development and aging, and effect of drugs. The final section 5, "Role in Human Disease" discusses physiological function and effects of altered levels in humans and animal models including complete absence due to a submicroscopic chromosomal deletion in several human patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2290855     DOI: 10.1016/0163-7258(90)90064-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  50 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas.

Authors:  Huiping Zhang; Graeme N Smith; Xudong Liu; Jeanette J A Holden
Journal:  Physiol Genomics       Date:  2010-03-23       Impact factor: 3.107

3.  Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

Authors:  Erika M Milczek; Daniele Bonivento; Claudia Binda; Andrea Mattevi; Ian A McDonald; Dale E Edmondson
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

4.  Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.

Authors:  San-Yuan Huang; Wei-Wen Lin; Fang-Jung Wan; Ai-Ju Chang; Huei-Chen Ko; Tso-Jen Wang; Pei-Lin Wu; Ru-Band Lu
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

5.  Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model.

Authors:  Daisuke Ekuni; James D Firth; Tarun Nayer; Takaaki Tomofuji; Toshihiro Sanbe; Koichiro Irie; Tatsuo Yamamoto; Takashi Oka; Zhenzi Liu; Juergen Vielkind; Edward E Putnins
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

6.  The role of monoamine metabolism in oxidative glutamate toxicity.

Authors:  P Maher; J B Davis
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

Review 7.  Biochemistry and pharmacology of moclobemide, a prototype RIMA.

Authors:  W Haefely; W P Burkard; A M Cesura; R Kettler; H P Lorez; J R Martin; J G Richards; R Scherschlicht; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  In silico identification of novel and selective monoamine oxidase B inhibitors.

Authors:  Kemal Yelekçi; Bora Büyüktürk; Nurdan Kayrak
Journal:  J Neural Transm (Vienna)       Date:  2012-12-15       Impact factor: 3.575

Review 9.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.

Authors:  T Iwasa; H Sano; A Sugiura; N Uchiyama; K Hara; H Okochi; K Nakagawa; T Yasumori; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.